The Global Prenatal Diagnostics Market is estimated at US$2.86 Billion in the year 2020, is projected to reach a revised size of US$8.6 Billion by 2027, growing at a CAGR of 8.3% over the period 2020-2027. The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.

According to the Centers for Disease Control and Prevention, in 2012 the U.S. the rate of perinatal mortality was stable, stillbirth affects about 1% of all pregnancies, and each year about 24,000 babies are stillborn. Medical care during pregnancy has improved over past decades but some issues regarding prenatal care are unchanged such as the rate of early stillbirth has remained about the same over time. Creating awareness among countries about prenatal testing will aid in lowering the number of prenatal disorders shortly.

Report Scope:

This global prenatal diagnostics market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global prenatal diagnostics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2030. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global pharmaceutical outsourcing market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.   

Growth Mapping

The key purpose of the report is to provide a growth map of the prenatal diagnostics market and hence assist the client's in the formulation of required strategies to meet the business goals. Thus, there are many qualitative and quantitative tools used for growth mapping of the market. These include PESTEL analysis for various regions involved in the market, SWOT analysis of the industry, PORTER'S five forces for determination of different attributes such as the power of the buyer and supplier engaged in the market, the threat of substitution, the intensity of competition, and the threat of the new entrants in the market.

Regional Analysis

The global demand for prenatal diagnostics is segmented by geography into North America, Asia Pacific, Europe, Latin America and the Middle East, and Africa. North America dominated and led the global prenatal diagnostics market. The factors that have contributed to the growth of this region are the growing efforts of collaborations between companies and hospitals and the increasing penetration of testing procedures.

For many established market players, the Middle East and the Asia Pacific have remained untapped territories. Therefore, the major corporations are planning to move into this area with better marketing strategies and positioning. This, in turn, is expected to increase the market growth. In addition, government-sponsored research programs, growing disposable incomes, increasing maternal paranoia for their child's wellbeing are going to support the market growth of non-invasive prenatal diagnostics.

Key Companies & Market Share Insights

Some of the major market players in prenatal testing market globally include Laboratory Corporation of America Holdings, Sequenom, Quest Diagnostics, Illumina, Inc., GeneDx., Ariosa Diagnostics, Natera, Inc., Ravgen, Counsyl, Inc., Eurofins NTD Inc., PREMAITHA HEALTH and Prenatal Paternities Inc. The report covers exhaustive analysis on:

Competitors Identified in This Market Include, Among Others:

ANGLE Plc

Berry Genomics Co. Ltd.

BGI Genomics

Hoffmann-La Roche Ltd.

Hologic Inc.

Illumina Inc.

Laboratory Corporation of America® Holdings

Lifecodexx AG

Natera Inc.

Quest Diagnostics Inc.

Ravgen Inc.

Sequenom Inc.

Segmentation by Test Type of Prenatal Testing

First-trimester screening tests

Cell-free fetal DNA testing

Early ultrasound

Cystic fibrosis

Second-Trimester Screening Tests

Quad Screen Test

Amniocentesis

Ultrasound

Glucose Screening

Third-trimester Screening Tests

Group B Strep Screening

Diagnostic tests

Chorionic villus sampling

Segmentation by End User of Prenatal Testing

Hospitals

Pathology Labs

Gynecology Clinics

Research Organizations

The Report Answers Questions Such As:

1. What is the global prenatal diagnostics market's competitive position?

2. What is the size of the prenatal diagnostics market globally?

3. What are the key factors driving the growth in the global prenatal diagnostics market during the forecast period?

4. What are the opportunities in the global prenatal diagnostics market?

5. Which are the main product fields to be invested in over the projected period in the global prenatal diagnostics market?